ZFP36 and breast cancer: MiR‐423 has been proved to be an oncogene that promotes the malignant breast cancer (BC) cells proliferation and migration, can inhibit the expression of ZFP36 in BC cells, and activate Wnt/β‐catenin signaling pathway, ultimately affecting the chemoresistance and apoptosis rate of BC cells.68